Yaz News | Yaz Side Effects 2013

A Yaz side effect lawsuit was filed in the Superior Court of the State of California, San Francisco, on March 19, 2013.

The plaintiffs include five women who claim to have suffered from DVT (Deep Vein Thrombosis), and other injuries arising from the use of Yaz.

According to court documents, the women contest that Bayer HealthCare Pharmaceuticals – the manufacturer of Yaz, should have known its Yaz birth control product could cause DVT, and that it was a high-risk drug.

Warning from the FDA (Food and Drug Administration):


Thromboembolic Disorders and Other Vascular Problems

Based on presently available information on Yasmin, DRSP-containing COCs may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing the progestin levonorgestrel or some other progestins…

Women taking or who have taken birth control pills that contain Drospirenone have a sevenfold risk of developing blood clots compared to women who take birth control pills that contain levonorgestrel (a synthetic progestogen).

On April 11 2012, the FDA ordered Bayer to provide stronger and more clear warnings on their packaging labels of Yaz and Yasmin blood-clot dangers.

Today, there are more than 13,000 pending Yaz lawsuits, yet Yaz, Yasmin and Ocella remain some of Bayer’s highest-selling pharmaceuticals.

Anyone affected by pulmonary embolism, blood clots, DVT or stroke after taking Yaz, Yasmin, BeYaz, or Ocella should contact a Multi-district Litigation Lawyer (MDL) who handles Yaz cases.

To contact a MDL attorney that represents women who have been harmed by Yaz, Yasmin, BeYaz or Ocella either fill out the form to your right, or visit our site at The Maher Law Firm


BeYaz is a pill form of birth control, it was approved to prevent pregnancy, and is 99% effective when taken as directed.

BeYaz is sometimes prescribed for:

  • A daily dose of folate supplementation for women in their reproductive years
  • Treatment of PMDD -or- Premenstrual Dysphoric Disorder
  • Treatment of moderate acne in women over the age of 14

BeYaz can increase the risk of serious conditions,  including:  Blood clots, Stroke, and Heart Attack, which can be life threatening or lead to permanent disability.

Contact your health care provider if you have any of the following symptoms:  Migraine headaches, Numbness in legs or arms, Trouble speaking, Severe pain in your chest, Persistant leg pain, Blindness – partial or complete.

Bayer Health Care (the manufacturer of BeYaz) in cooperation with the FDA (Food and Drug Administration) has recently updated the product information for BeYaz to say:

“Women who use birth control pills with drospirenone (like Beyaz) may have a higher risk of getting a blood clot. Some studies reported that the risk of blood clots was higher for women who use birth control pills that contain drospirenone than for women who use birth control pills that do not contain drospirenone. Blood clots can be life-threatening or lead to permanent disability. Talk to your healthcare provider about your risk of blood clots before deciding which Pill is right for you.”

You have the right to trust your medication is safe.  Tragically, this is not always the case.  Well versed in the product liability laws that protect consumers, our court appointed Yaz, Yasmin, Ocella and BeYaz MDL (Multi-district Litigation) attorney are here to help.  We represent you, we do not represent drug manufacturers or insurance companies. We invite you to contact The Maher Law Firm or Frank Eidson Attorney At Law today.

What We Now Know About Yaz, Yasmin and Ocella

Once Upon A Time………Yaz, Yasmin and Ocella were thought to be “different” forms of birth control that would helped offer some relief for those suffering from  PMDD (Premenstrual Dysphoric Disorder)

We now know that Yaz, Yasmin and Ocella birth control pills have a 74% increased risk for blood clots or venous thromboembolism, due to the synthetic progestin hormone known as Drospirenone.  Blood clots can break loose from the vein, move through the body and into the lungs, causing a pulmonary embolism which can result in death.

Each Yaz, Yasmin and Ocella birth control pill contains 3mg of Drospirenone.

As of April 2012, the FDA (Food and Drug Administration) required new labeling for birth control pills containing drospirenone that include the following information:

    • A summary of the previously released results of the FDA funded study regarding the blood clot risk.
    • That some epidemiologic studies show as high as a threefold increased risk for blood clots for birth control pills containing drospirenone.

Drospirenone also suppresses the secretion of the hormones that regulate the body’s water and electrolytes, which may cause higher potassium levels.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

Yaz, Yasmin, Ocella Multidistrict Litigation Attorneys

Steve Maher is a MDL (Multi-district Litigation) attorney representing  women who have been harmed by Yaz, Yasmin and Ocella.

Yaz, Yasmin and Ocella are dangerous drugs that can potentially harm you and your loved ones.

Yaz and Yasmin contain estrogen (in the form of ethinyl estradiol) and Progestin (in the form of the synthetic hormone drospirenone)

The FDA has concluded that birth control pills containing Drospirenone have a 74% increased risk  for blood clots or venous thromboembolism.

Yaz and Yasmin have been known to cause heart attacks, strokes and deep vein thrombosis.  Yaz and Yasmin have been linked to 50 deaths in women as young as 17 and hundreds of injuries.

Bayer AG, based in Leverkusen, Germany manufactures Yaz, Yasmin and Ocella and has to date settled Yaz Lawsuits totaling over $402 million.

The company, originally put aside a total of $246 million U.S. dollars in 2010 and 2011, according to securities filings, and has now more than doubled it’s reserve for Yaz and Yasmin cases to $610.5 million U.S. dollars.

If you or a loved one has been harmed by this dangerous drug, Steve Maher can help.  Steve does not represent drug manufacturers or insurance companies, Steve represents you and your loved ones.

For a FREE no obligation case evaluation, contact The Maher Law Firm today at 1-888-884-1507


Yaz, Yasmin Lawsuit Settlements, $402 Million And Counting

Bayer AG pays out an average of $212,000 per Yaz and Yasmin case

In a stockholders’ newsletter in July, Bayer said that it’s resolved almost 1,900 cases in which it’s alleged that its Yasmin and Yaz contraceptives caused clots that can lead to heart attacks and strokes.

Bayer AG, based in Leverkusen, Germany put aside a total of $246 million U.S. dollars in 2010 and 2011, according to securities filings, and has now more than doubled it’s reserve for Yaz and Yasmin cases to $610.5 million U.S. dollars.

Bloomberg Report - In an emailed statement, Bayer officials said “We believe we have made appropriate provisions for most of the cases we consider to be worthy of settlement with these accounting measures.”

It is said that Bayer may have to pay more than 2.5 Billion U.S. dollars to resolve all the cases over Yaz and Yasmin.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have a right to compensation for your injuries. The Yaz and Yasmin Lawyers at The Maher Law Firm would like to help. We invite you to contact our trial-tested dangerous drug attorneys today.

Judge Delays Start of First Yaz Trial by Ordering Suits into Mediation

The first Yaz trial, which involves a plaintiff who suffered a pulmonary embolism after taking the drospirenone-containing birth control pill, was set to begin on January 9th. However, the federal judge overseeing thousands of Yaz, Yasmin and Ocella venous thromboembolism lawsuits, instead ordered that all involved parties meet with a special mediator in order to negotiate a settlement for the litigation.

Judge Herndon’s December 31st order has delayed the start of a trial that was likely going to help both the prosecution and the defense gauge how juries would react and respond to the evidence presented in many of the cases. Stephen Saltzburg, a professor at the George Washington School of Law, was the Special Master appointed to mediated the entire litigation.

To date, more than 10,500 women have filed product liability lawsuits against Bayer AG, alleging that they suffered injuries as a result of Bayer’s failure to properly warn users of the potentially dangerous side effects of Yasmin, Yaz and other drospirenone-containing birth control pills.

According to a recent report by the U.S. Food and Drug Administration, birth control pills that contain drospirenone, a new kind of synthetic progestin, may increase the risk for blood clots by as much as 75 percent over older-generation birth control pills.

FDA Will Soon Decide Fate of Bayer’s Risky Birth Control Pill, Yaz

It seems that the fate of Bayer’s new-generation birth control pill, Yaz, is in the hand of the U.S. Food and Drug Administration, as the regulatory agency meets on December 8th in order to determine whether or not the drug should be allowed to stay on the market.

Based on the results of an agency-funded study of drospirenone-contanting contraceptives, Yaz and other similar products were found to carry a 1.5-fold increased risk for causing potentially lethal blood clots compared to older-genration hormonal contraceptives.

To date, almost 10,000 lawsuits have been filed against Bayer, citing that Yaz caused blood-clot related heart attacks, strokes and even death. In fact, more than 190 women have died as a result of taking the drug.

Given the overwhelming evidence in support of the fact that blood clot events are far more likely to occur from pills containing drospirenone than from those containing levonorgestrel, an older progestin ingredient, the FDA will have to determine whether or not these products should remain on the market. This is a complex issue for the pharmaceutical industry, as drug makers contend that patients will still demand additional options, despite the proven risks associated with using a particular finished drug product. Moreover, the sense of urgency surrounding the issue continues to grow due to the fact that Yaz has gone off-patent, allowing for increased competition from generic products like Ocella, Safyral, Syeda and Zarah.

One thing remains clear, blood clots are extremely dangerous and unpredictable, which is why the FDA’s December 8th meeting is of the utmost importance.

Mother Takes Daughter Off Yaz after UnExplained Illness

Birth Control Buzz is a website dedicated helping women find the best and best priced birth control pills for themselves. They also have a forum where people can post their experiences both good and bad with various pills. There, one mother wrote:  “My daughter was taking Yaz as a predecessor to going on Acutane for acne. After a couple months began having severe nausea and vomiting which we thought was due to the Acutane (it is known to have potentially powerful side effects) so we took her off of that treatment. The nausea and vomiting increased to the extent that she had MRI, sonogram, and ultimately colonoscopy and endoscopy to determine if there was cancer, etc. All tests were totally clean…so doctors said it must be in her head.”

As it turned out it wasn’t just “in her head”; The mother was able to trace the start of her daughter’s problems back and found it coincided with the start of the Yaz prescription. She writes:  “I immediately told her to stop taking the drug. Within one week, my daughter could eat again and her spirits were lifted.  Nice to have her back after thousands of dollars in medical tests.”

Yaz has caused adverse side effects for many women, including life-threatening cases of pulmonary embolism, deep vein thrombosis, and even stroke. Lawsuits have been and continue to be filed against Bayer, makers of Yaz.

Yaz Side Effects Called “Multiple Rare Events” by Bayer

In a New York Times article on Yaz and its dangerous side effects, Dr. Grimes a paid consultant for Bayer was quoted as saying “a multiple of a rare event is still a rare event.”

This could be true, if we were talking about two headed snakes, or volcanoes. But when thinking of women’s healthcare and prescriptions, does it apply?

By this logic, women developing life threatening blood clots after taking Yaz is rare. The fact that it happens to many women all over the US and the world, is just “multiple” rare events. It begs the question, how many life threatening and fatal “rare events” need to occur before it becomes a common event?